Drug-Industry Middlemen are Exploiting Patients

Last month, lawmakers missed a big chance to lower the cost of prescription medicine.

Despite including a host of new drug-pricing measures in the Inflation Reduction Act (IRA), legislators did almost nothing to crack down on some of the worst actors in the entire healthcare system — the "pharmacy benefit managers" and other supply-chain intermediaries who routinely raise drug costs and deny consumers access to life saving drugs.

Fortunately, there's no reason they can't act when they return to Washington this month.